Antibiotic resistance spreads through bacterial populations via horizontal gene transfer — resistance genes copy themselves from one bacterium to another through conjugation, a process resembling bacterial mating. The spread is relentless because the resistant bacteria have a selective advantage: in the presence of antibiotics, they survive while sensitive bacteria die. Every new antibiotic creates a new selection pressure that resistance genes eventually overcome.
Published in npj Antimicrobials and Resistance, Bier, Nizet, and colleagues at UC San Diego developed a second-generation Pro-Active Genetics system called pPro-MobV. It uses the same conjugation mechanism that spreads resistance to instead spread a CRISPR cassette that disables resistance genes. The system travels through the natural mating channels formed between bacteria, entering biofilms — the protective colonies where antibiotics fail — and dismantling resistance genes from within.
The structural insight is about turning the channel against its cargo. Conjugation is the route by which resistance spreads. The same route can carry a genetic payload that destroys resistance. The elegance is not in the CRISPR machinery itself but in the delivery mechanism: by hitchhiking on the same transfer system that created the problem, the solution propagates through the same networks, reaching the same protected biofilm interiors that antibiotics cannot penetrate. The weapon and the disease use the same highway. The question is which replicates faster — the resistance gene that confers survival advantage, or the CRISPR cassette that removes it. In a population where antibiotics are present, the CRISPR system makes bacteria sensitive again, and the antibiotics do the rest.